In FY25, India's pharmaceutical exports reached a record high, surpassing $30 billion (approximately $30.47 billion), a ...

Proposal aims to build a database of bulk drug traders, improve traceability of imported raw materials, over 70% of which ...

India’s pharmaceutical exports reached $30.47 billion in FY 2024–25, registering a 9.4 per cent year-on-year growth, and are ...

A parliamentary panel’s recent criticism of India’s drug price control mechanism has kept industry circles buzzing as the ...

Entering 2026, India's pharmaceutical industry initiates a crucial five-year plan to evolve into an innovation hub, aiming for a USD 500 billion valuation by 2047.

Sun Pharma's Managing Director, Kirti Ganorkar, predicts that new age medicines for obesity and diabetes will drive the ...

In 2025, the BSE Healthcare Index which is represented by mostly pharma companies underperformed the Sensex, declining ...

Pharma industry leaders spotlight quality, sustainability and market diversification as export priorities for 2026: Our ...

The year also reinforced a long-standing strength of Indian pharma: its ability to scale through strategic consolidation.

Close to three decades back, when Indian pharma firms began to move into the US market, they faced many challenges. And the ...

The year 2025 has been a significant one for the Indian pharmaceutical sector. It witnessed several novel launches, ...